Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Doorbraak maakt vroeg opsporen neurologische ziekten mogelijk
sep 2025 | Bewegingsstoornissen, Dementie, Neuro-vasculair